The international surgical journal with global reach

This is the Scientific Surgery Archive, which contains all randomized clinical trials in surgery that have been identified by searching the top 50 English language medical journal issues since January 1998. Compiled by Jonothan J. Earnshaw, former Editor-in-Chief, BJS

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study). Cancer 2016; 122: 574-581.

Published: 27th July 2016

Authors: Leone F, Marino D, Cereda S, Filippi R, Belli C, Spadi R et al.

Conclusion

In this study that included 89 patients, the addition of panitumumab did not improve progression-free survival: 5.3 versus 4.4 months with placebo. Overall survival was similarly unaffected.

Pubmed Link